Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | ARRATIA DIAZ, P. |
| Género | - |
| Área Principal WOS | Cardiac & Cardiovascular Systems; Peripheral Vascular Disease; Clinical Neurology; |
| Afiliación Principal | Hosp Salvador |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| WOS | #Pub |
|---|---|
| Cardiac & Cardiovascular Systems | 4 |
| Peripheral Vascular Disease | 3 |
| Clinical Neurology | 2 |
| Hematology | 1 |
| Scopus | #Pub |
|---|---|
| Cardiology And Cardiovascular Medicine | 1 |
| SciELO | #Pub |
|---|
| Autor | Género | # Pub |
|---|---|---|
| FLORENZANO, FERNANDO | Hombre | 6 |
| OPAZO, MARIA-JOSE | Mujer | 1 |
| PINCETTI, CRISTIAN | Hombre | 6 |
| PARADA, ANDRES | Hombre | 1 |
| RETAMAL MATUS, L. | - | 6 |
| REBOLLEDO, C. | - | 6 |
| MANRIQUEZ SILVA, L. | Hombre | 6 |
| CARMONA PEREZ, M. | - | 6 |
| CAMPISTO, Y. | - | 6 |
| GRANDON AZUA, M. | - | 6 |
| BUGUENO, CLAUDIO | Hombre | 6 |
| RODRIGUEZ, V. | Hombre | 6 |
| OPAZO, MARGARET | Mujer | 5 |
| BALBOA, W. | - | 6 |
| COBOS, J. | Hombre | 6 |
| LOPETEGUI, M. | - | 6 |
| ROMERO LLAMAS, R. | - | 6 |
| ZAPATA STAUB, J. | - | 6 |
| LARA LARA, C. | - | 6 |
| MARTINEZ, D. | Hombre | 6 |
| PARADA-DAZA, ALEJANDRA | Mujer | 5 |
| OBREQUE-NINEZ, CARLOS | Hombre | 6 |
| CORBALAN-HERREROS, RAMON LUIS | Hombre | 6 |
| YOVANINIZ, PATRICIO | Hombre | 6 |
| POTTHOFF, SERGIO | Hombre | 6 |
| STOCKINS F, BENJAMÍN | Hombre | 6 |
| MONDACA, PILAR | Mujer | 6 |
| SAKAGAMI, SATORU | Hombre | 6 |
| MANRIQUEZ, L. | Hombre | 6 |
| TORRES CARRASCO, G. | - | 2 |
| Palabra Clave | #Pub |
|---|---|
| atrial fibrillation | 4 |
| warfarin | 3 |
| stroke | 3 |
| edoxaban | 3 |
| metaanalysis | 2 |
| prevention | 2 |
| oral anticoagulants | 2 |
| dabigatran | 2 |
| bleeding | 2 |
| anticoagulation | 2 |
| outcomes | 1 |
| anticoagulant | 1 |
| utility | 1 |
| update | 1 |
| thromboembolism | 1 |
| therapy | 1 |
| stroke prevention | 1 |
| rivaroxaban | 1 |
| risk factors | 1 |
| quality-of-life | 1 |
| quality of life | 1 |
| apixaban | 1 |
| predicting stroke | 1 |
| persistent | 1 |
| cerebral hemorrhage | 1 |
| association task-force | 1 |
| myocardial-infarction | 1 |
| mortality | 1 |
| american-college | 1 |
| management | 1 |
| intensity | 1 |
| inhibition | 1 |
| hemorrhage | 1 |
| guidelines | 1 |
| bioprosthetic valve | 1 |
| cost-effectiveness | 1 |
| collaboration | 1 |
| clinical trial | 1 |